Candel Therapeutics Inc (CADL)

Cost of Revenue

$0.00

TTM · Period ending: · USD

CADL logo

CADL Cost of Revenue

Latest reported$0.00
CADL TTM Cost of Revenue ($3.42M → $0.00)
High-resolution chart · PNG

CADL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Candel Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
276,000
276,000
276,000
276,000
178,000
178,000
3,470,000
6,223,000
6,045,000
6,045,000
4,548,000
3,416,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.